These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12469798)

  • 41. Microvascular permeability with sulfonylureas in normal and diabetic hamsters.
    Bouskela E; Cyrino FZ; Conde CM; Garcia AA
    Metabolism; 1997 Dec; 46(12 Suppl 1):26-30. PubMed ID: 9439555
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Morphology and stress-strain properties along the small intestine in the rat.
    Dou Y; Zhao J; Gregersen H
    J Biomech Eng; 2003 Apr; 125(2):266-73. PubMed ID: 12751289
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of gliclazide on prostaglandin I2 formation in normal and streptozotocin-induced diabetic animals.
    Fujitani B; Maeda J; Tsuboi T; Kadokawa T; Shimizu M
    Jpn J Pharmacol; 1983 Oct; 33(5):965-70. PubMed ID: 6358588
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modulatory effects of resveratrol on attenuating the key enzymes activities of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats.
    Palsamy P; Subramanian S
    Chem Biol Interact; 2009 May; 179(2-3):356-62. PubMed ID: 19059388
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of aqueous extract of Cyamopsis tetragonoloba Linn. beans on blood glucose level in normal and alloxan-induced diabetic rats.
    Mukhtar HM; Ansari SH; Ali M; Bhat ZA; Naved T
    Indian J Exp Biol; 2004 Dec; 42(12):1212-5. PubMed ID: 15623233
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antidiabetic effect of mangiferin in combination with oral hypoglycemic agents metformin and gliclazide.
    Sekar V; Mani S; Malarvizhi R; Nithya P; Vasanthi HR
    Phytomedicine; 2019 Jun; 59():152901. PubMed ID: 30981189
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diabetic endothelial dysfunction: effect of free radical scavenging in Type 2 diabetic patients.
    De Mattia G; Laurenti O; Fava D
    J Diabetes Complications; 2003; 17(2 Suppl):30-5. PubMed ID: 12623166
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural and functional characteristics of muscle from diabetic rodent small intestine.
    Nowak TV; Harrington B; Weisbruch JP; Kalbfleisch JH
    Am J Physiol; 1990 May; 258(5 Pt 1):G690-8. PubMed ID: 2185667
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Morpho-mechanical intestinal remodeling in type 2 diabetic GK rats--is it related to advanced glycation end product formation?
    Zhao J; Chen P; Gregersen H
    J Biomech; 2013 Apr; 46(6):1128-34. PubMed ID: 23403079
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Probiotic treatment reduces blood glucose levels and increases systemic absorption of gliclazide in diabetic rats.
    Al-Salami H; Butt G; Fawcett JP; Tucker IG; Golocorbin-Kon S; Mikov M
    Eur J Drug Metab Pharmacokinet; 2008; 33(2):101-6. PubMed ID: 18777945
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Small intestinal morphometric and biomechanical changes during physiological growth in rats.
    Lu X; Zhao J; Gregersen H
    J Biomech; 2005 Mar; 38(3):417-26. PubMed ID: 15652539
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effect of blood glucose control after small intestine exclusion surgery in Goto-Kakizaki rat with type 2 diabetes mellitus].
    Wang Y; Zhang ZZ; Wang L; Deng ZZ; Jiao YB; Zou ZD
    Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(40):2858-61. PubMed ID: 20137669
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of streptozotocin-induced diabetes mellitus on release of vasoactive intestinal polypeptide from rodent small intestine.
    Nowak TV; Chey WW; Chang TM; Weisbruch JP; Fouquet G
    Dig Dis Sci; 1995 Apr; 40(4):828-36. PubMed ID: 7720477
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low-residue diet fed to rabbits induces histomorphological and biomechanical remodeling of small intestine.
    Liu Y; Zhao J; Liao D; Bao L; Gregersen H
    Neurogastroenterol Motil; 2017 Apr; 29(4):. PubMed ID: 27790839
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Applying the Taguchi design for optimized formulation of sustained release gliclazide chitosan beads: an in vitro/in vivo study.
    Varshosaz J; Tavakoli N; Minayian M; Rahdari N
    AAPS PharmSciTech; 2009; 10(1):158-65. PubMed ID: 19205888
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of the semisynthetic bile acid MKC on the ileal permeation of gliclazide in vitro in healthy and diabetic rats treated with probiotics.
    Al-Salami H; Butt G; Tucker I; Mikov M
    Methods Find Exp Clin Pharmacol; 2008 Mar; 30(2):107-13. PubMed ID: 18560625
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gliclazide reduces MKC intestinal transport in healthy but not diabetic rats.
    Al-Salami H; Butt G; Tucker I; Fawcett PJ; Golocorbin-Kon S; Mikov I; Mikov M
    Eur J Drug Metab Pharmacokinet; 2009; 34(1):43-50. PubMed ID: 19462928
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The influence of 3alpha,7alpha-dihydroxy-12-keto-5beta-cholanate on gliclazide pharmacokinetics and glucose levels in a rat model of diabetes.
    Mikov M; Al-Salami H; Golocorbin-Kon S; Skrbic R; Raskovic A; Fawcett JP
    Eur J Drug Metab Pharmacokinet; 2008; 33(3):137-42. PubMed ID: 19007038
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gliclazide increases glucose utilization by rat intestine in vitro.
    Tormo MA; Zubeldia MA; Montero JL; Campillo JE
    Diabete Metab; 1989; 15(4):170-5. PubMed ID: 2806703
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antioxidant and vascular effects of gliclazide in type 2 diabetic rats fed high-fat diet.
    Sena CM; Louro T; Matafome P; Nunes E; Monteiro P; Seiça R
    Physiol Res; 2009; 58(2):203-209. PubMed ID: 18380531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.